ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Adverse effects"

  • 2021 American Transplant Congress

    Outcomes of Granulocyte-Colony Stimulating Factor Use in Pediatric Renal Transplant Recipients: A Pediatric Nephrology Research Consortium Study

    R. M. Engen1, P. L. Weng2, W. Shih3, H. Patel4, K. Richardson5, S. Dowdrick6, I. Ashoor7, J. Misurac8, A. Z. Traum9, M. Semanik10, N. G. Jain11, R. Sreedharan12

    1Northwestern University, Chicago, IL, 2University of California Los Angeles, Los Angeles, CA, 3University of Michigan, Ann Arbor, MI, 4Nationwide Children's Hospital, Columbus, OH, 5Oregon Health & Science University, Portland, OR, 6Penn State Health, Hershey, PA, 7Louisiana State University, New Orleans, LA, 8University of Iowa, Iowa City, IA, 9Harvard University, Boston, MA, 10University of Wisconsin-Madison, Madison, WI, 11Columbia University, New York, NY, 12Medical College of Wisconsin, Milwaukee, WI

    *Purpose: Neutropenia is common after pediatric kidney transplant and is associated with an increased risk of bacterial infection, allograft loss, and death. Granulocyte colony-stimulating factor…
  • 2021 American Transplant Congress

    Non-Alcoholic Fatty Liver Disease in Non-Liver Transplant Patients

    R. Claudio1, C. Conceicao2, K. Robichaux2, A. Kumar1, J. Buggs3, N. Kemmer4

    1Morsani College of Medicine, University of South Florida, Tampa, FL, 2Honors College, University of South Florida, Tampa, FL, 3Transplant Surgery, Tampa General Hospital, Tampa, FL, 4Transplant Hepatology, Tampa General Hospital, Tampa, FL

    *Purpose: The global prevalence of non-alcoholic fatty liver disease (NAFLD) is rising at an alarming rate, driven in large part by an increased incidence of…
  • 2020 American Transplant Congress

    Largest Experience of Safety, and Efficacy of Patiromer in Solid Organ Transplants (SOT)

    P. Singh1, H. Winters2, T. E. Pesavento1, K. Schnelle2

    1Transplant Nephrology, Ohio State University, Columbus, OH, 2Transplant Pharmacy, Ohio State University, Columbus, OH

    *Purpose: Hyperkalemia, a potentially life‐threatening electrolyte abnormality, is commonly seen SOT. The predisposing factors are renal-dysfunction, and medications (CNI, TMP-SMX, ACEI, and ARBs). Patiromer, a…
  • 2020 American Transplant Congress

    Effects of Tenofovir and Entecavir on Glomerular Kidney Function in Liver Transplant Patients: A Nationwide Cohort Study

    J. Lee1, E. Kim1, S. Yang1, S. Kim1, J. Lee1, J. Park2, H. Choi3, B. Kim2, D. Joo1, S. Kim1, M. Kim1

    1Department of Transplantation Surgery, Severance Hospital, Seoul, Korea, Republic of, 2Department of Internal Medicine, Severance Hospital, Seoul, Korea, Republic of, 3Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of

    *Purpose: Entecavir and tenofovir are currently the first-line drugs in liver transplantation (LT) patients for the prevention of hepatitis B virus recurrence. Despite its proven…
  • 2020 American Transplant Congress

    Outcomes of Kidney Transplant Recipients with Depression and Anxiety

    D. Keys, S. Jackson, S. M. Riad, R. Spong, A. Matas

    University of Minnesota, Minneapolis, MN

    *Purpose: The outcomes of kidney transplantation in patients with depression and anxiety have been limited by small numbers. This is despite high prevalence of these…
  • 2020 American Transplant Congress

    An Evaluation of Converting Elderly Kidney Transplant Recipients from Tacrolimus to LCPT to Limit Neurological Adverse Events and Improve Quality of Life

    A. Reticker, B. Valdepenas, K. Bruno, D. Cikopana, S. Walton, E. Benedetti, I. Tzvetanov, P. West-Thielke

    University of Illinois, Chicago, IL

    *Purpose: Adverse effects (AEs) of tacrolimus significantly reduce recipients’ quality of life (QOL). Given its ability for tremor improvement, this study investigates whether conversion from…
  • 2020 American Transplant Congress

    Relationship between Tacrolimus Levels and Short-Term Outcome in Korean Pediatric Patients with Liver Transplantation

    H. Lim1, H. Koh1, S. Kim1, S. Park1, Y. Kang2, M. Kim3, K. In1

    1Severance Pediatric Liver Diseases Research Group, Severance Children’s Hospital, Severance Hospital, Seoul, Korea, Republic of, 2Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, , Wonju Severance Christian Hospital, Seoul, Korea, Republic of, 3Division of Transplantation Surgery, Department of General Surgery, Severance Hospital, Seoul, Korea, Republic of

    *Purpose: Liver transplantation (LT) is a life-saving procedure in patients with end stage liver disease. After LT, immunosuppresive regimens are needed in order to prevent…
  • 2020 American Transplant Congress

    Long Term Ursodeoxycholic Acid Use Does Not Alter Long Term Rejection, Biliary Complication, Mortality or Hospitalization Rates after Liver Transplantation

    T. Ashraf1, V. Mendiratta2, S. Gill1, A. Abdelwahab3, D. Moonka2, S. Jafri2

    1Internal Medicine, Henry Ford Hospital, Detroit, MI, 2Gastroenterology and Hepatology, Henry Ford Hospital, Detroit, MI, 3Wayne State University, Detroit, MI

    *Purpose: Endogenous bile acids are suspected to contribute to hepatobiliary injury after liver transplantation through direct cytotoxic effects. Ursodeoxycholic acid (UDCA) has been shown to…
  • 2020 American Transplant Congress

    Pharmacokinetics of Maribavir in Subjects with Moderate Hepatic Impairment

    I. H. Song1, K. Ilic2, J. Wu3

    1Quantitative Clinical Pharmacology, Shire, a Takeda Company, Lexington, MA, 2Rare Disease TAU, Shire, a Takeda Company, Lexington, MA, 3Biostat, Shire, a Takeda Company, Lexington, MA

    *Purpose: Maribavir, an investigational agent for cytomegalovirus (CMV) infection in transplant recipients, has received Breakthrough Therapy Designation. Maribavir is metabolized primarily in the liver through…
  • 2020 American Transplant Congress

    Optimal Transition for Transplant Recipients: A Model of Care in an Integrated Health Care System

    S. Zheng1, L. Pravoverov1, A. Nazarova1, D. Adey2, N. B. Goes1

    1The Permanente Medical Group, San Francisco, CA, 2Kidney and Transplantation Program, University of California San Francisco, San Francisco, CA

    *Purpose: Transplantation is the treatment of choice for ESRD. While short-term outcomes have improved, long-term outcomes lag. Many factors may explain the long-term lag including…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 18
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences